New initiative will accelerate the transformation of academic research into high-tech companies and industrial ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

True patient-centricity will drive commercial success as CGT moves beyond first-generation therapies. Current timelines in CGT, from diagnosis to treatment, can exceed six months, often compounded by ...

Be excited about the future growth opportunity of your company, but also be diligent in planning for that transition, and be wary of the pitfalls that will seek to stop you. The Fast Company Executive ...

Rigetti Computing recently confirmed that CEO Subodh Kulkarni and CFO Jeff Bertelsen will meet investors and host a fireside chat at the 28th Annual Needham Growth Conference, while filings revealed a ...

In thinking about the economics around the launch of pharmaceutical products, it is useful to compare the situation to another area that has seen its economics evolve in recent years: space travel.

The pharmaceutical commercialization landscape is becoming increasingly complex. Tried and true paradigms for capturing market share and securing reimbursement must evolve in the face of demand for ...

In the weeks following its third quarter 2025 results, Dyadic Applied BioSolutions, Inc. (NASDAQ:DYAI) announced several new partnerships and partnership expansions that build on its foundation of ...